Table:
begin	end	state
1	6	cytoplasmic
7	27	transmembrane
28	32	non-cytoplasmic
33	53	transmembrane
54	64	cytoplasmic
65	83	transmembrane
84	88	non-cytoplasmic
89	108	transmembrane
109	114	cytoplasmic
115	134	transmembrane
135	162	non-cytoplasmic
163	181	transmembrane
182	211	cytoplasmic
212	232	transmembrane
233	250	non-cytoplasmic
251	274	transmembrane
275	285	cytoplasmic
286	305	transmembrane
306	602	non-cytoplasmic

Input:
>WP_093394842.1 NCBI__GCF_900114975.1:WP_093394842.1
MRVEKKTAIYFPALICLSLSGLFLPSFIKNDYLFVILNVVAFNGIAVTGLNLLYDATGQV
SLGHAVFYGLGAYTTAVLSVTFGLPLWTAWMGSVAMVLVSSFILAFPTLRLHGHYMVMAT
LGCNIILTVILNQWESLTGGPSGFPGIPELSAGFVELSTDRGFFRLAWIALLGFAFATVA
LQKSGVGKIFRAIRQNEIATECCGTNTTGYKIFAFVLSALYAGIAGILYAHYMSFISPKT
FGVFRSLEWVTMAVVGGMGNVLGGILGAFVLTLLPELLHALEELQVLFYGIVLMSVLILC
PQGMVPAIRSLVDRFSALTETEACGDKSLKKKTLRGATPVRAGRNCGKLRIEGLSVNFGG
LQALSSVSVTFDPGRIHAVIGPNGAGKTTLFNAVCGIVKPRSGKIFLGDLEITGFSPHKI
ALSGIGRTFQVPQLYSEFSVRDHVFVGMCVGRLPLNGMIGDDVDEVLRFFDLLELSELKV
GEVSLFDKKRIELARALAANPAYILVDEPGGGLNEEEKEAVARYLFALTKVGVTPIVVDH
HMDLVMNVAERVVVLHQGQIIADGTPDEIVENPRVADAYLGSRQKVLSGGRVERGCEGCG
NA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server